Ophthalmology – Ocular Ischemic Syndrome

Basics

Description

Ocular ischemic syndrome (OIS) is a spectrum of anterior and posterior segment abnormalities caused by chronic ocular hypoperfusion, most commonly from severe carotid occlusive disease.

It may affect:

• Retina
• Choroid
• Optic nerve
• Iris
• Ciliary body
• Anterior segment
• Orbit in very severe cases

The most common symptoms are:

• Progressive monocular visual loss
• Ocular or orbital pain

OIS is particularly important because it is a marker of severe systemic vascular disease and is associated with increased risk of:

• Stroke
• Myocardial infarction
• Cardiovascular death

Epidemiology

OIS is relatively uncommon but probably underdiagnosed.

Estimated incidence is approximately:

7–8 cases per million persons per year

Typical demographics include:

• Mean age around 65 years
• Usually age 50–80 years
• Male predominance, reflecting atherosclerotic vascular disease

Bilateral disease occurs in a minority of patients.

Risk Factors

Major risk factors are those for systemic atherosclerosis, including:

• Hypertension
• Diabetes mellitus
• Hyperlipidemia
• Smoking
• Coronary artery disease
• Peripheral vascular disease
• Previous TIA
• Previous stroke
• Advanced age

Pathophysiology

The fundamental mechanism is:

Reduced carotid/ophthalmic arterial flow + inadequate collateral circulation → chronic ocular hypoperfusion

This results in:

• Retinal ischemia
• Choroidal ischemia
• Ciliary body ischemia
• Anterior segment ischemia
• VEGF production
• Retinal and iris neovascularization

Severe ischemia may ultimately produce:

• Neovascular glaucoma
• Retinal vascular insufficiency
• Hypotony
• Profound visual loss

Etiology

Carotid Occlusive Disease

The most common cause is severe atherosclerotic disease of the carotid circulation.

Most commonly involved:

1. Internal carotid artery
2. Common carotid artery
3. Less commonly external carotid collateral pathways

Historically, OIS is most often associated with very high-grade carotid stenosis or complete occlusion.

However, the clinical severity depends not only on the percentage of stenosis but also on:

Adequacy of collateral circulation

Therefore, OIS can occasionally occur with less dramatic stenosis when collateral flow is poor.

Other Causes

Less common causes include:

• Ophthalmic artery occlusive disease
• Giant cell arteritis
• Takayasu arteritis
• Aortic arch disease
• Other large-vessel vasculitis
• Severe systemic hypotension
• Rare hypercoagulable or vaso-occlusive disorders

Commonly Associated Conditions

Frequently associated systemic diseases include:

• Hypertension
• Diabetes mellitus
• Coronary artery disease
• Previous stroke or TIA
• Peripheral arterial disease
• Dyslipidemia

Diagnosis

OIS should be suspected when an older patient with vascular risk factors develops:

• Unilateral progressive visual loss
• Ocular ache
• Midperipheral retinal hemorrhages
• Narrow retinal arteries
• Iris neovascularization
• Delayed choroidal filling on angiography

History

Visual Loss

Visual loss is the most common symptom.

It may be:

• Gradual over weeks to months
• Progressive
• Occasionally abrupt

Many patients present with visual acuity worse than:

20/60

Visual loss may arise from:

• Macular ischemia
• Retinal ischemia
• Neovascular glaucoma
• Cataract
• Optic nerve ischemia
• Retinal artery occlusion

Transient Monocular Visual Loss

Some patients experience:

Amaurosis fugax

This may present as:

• Transient dimming
• Curtain-like visual loss
• Brief monocular blindness

This should raise concern for significant carotid vascular disease.

Delayed Recovery After Bright Light

A characteristic symptom is:

Prolonged recovery of vision after exposure to bright light

The ischemic retina requires abnormally long to recover after photoreceptor bleaching.

This is an important clue to ocular hypoperfusion.

Ocular Pain

Approximately one-third to nearly one-half of patients experience:

Dull ocular or periorbital pain

Sometimes termed:

Ocular angina

Pain may result from:

• Ocular ischemia
• Elevated IOP from neovascular glaucoma

It is often described as:

• Dull
• Constant
• Periorbital or brow ache

Anterior Segment Findings

Possible findings include:

• Conjunctival injection
• Episcleral injection
• Corneal edema
• Descemet folds
• Mild anterior chamber inflammation
• Iris atrophy
• Iris neovascularization
• Posterior synechiae
• Anterior synechiae
• Cataract

Anterior Chamber Inflammation

Mild anterior uveitis may occur.

Typical pattern:

• Relatively prominent flare
• Fewer cells

This reflects ischemic disruption of the blood-aqueous barrier.

Iris Neovascularization

Rubeosis iridis is a major finding.

It results from:

Retinal ischemia → VEGF production → anterior segment neovascularization

It may progress to:

• Angle neovascularization
• Peripheral anterior synechiae
• Neovascular glaucoma

Intraocular Pressure

IOP may be:

• Elevated
• Normal
• Low

Elevated IOP

Usually due to:

• Neovascular glaucoma

Low IOP

May result from:

Ciliary body hypoperfusion and reduced aqueous production

This is an important distinction from many other ischemic retinal conditions.

Hypotony

Severe ciliary body ischemia may cause hypotony.

Consequences include:

• Corneal decompensation
• Cataract
• Hypotony maculopathy
• Progressive structural damage

Pupils

Possible abnormalities include:

• RAPD
• Sluggish response
• Semidilated pupil

depending on the degree of retinal and optic nerve ischemia.

Posterior Segment Findings

Posterior segment abnormalities are extremely important.

Typical findings include:

• Narrowed retinal arteries
• Dilated but relatively non-tortuous retinal veins
• Midperipheral retinal hemorrhages
• Microaneurysms
• Cotton-wool spots
• Retinal neovascularization
• Optic disc neovascularization
• Choroidal ischemia

Retinal Hemorrhages

A classic pattern is:

Dot-blot hemorrhages predominantly in the midperipheral retina

This contrasts with CRVO, where hemorrhages are often:

• More diffuse
• Present in all quadrants
• Associated with more tortuous veins

Retinal Veins

OIS typically shows:

Dilated but not markedly tortuous veins

This is an important clue distinguishing OIS from CRVO.

Microaneurysms

Microaneurysms are often:

• Numerous
• Midperipheral

They may become particularly apparent on fluorescein angiography.

Retinal Arterial Pulsations

Spontaneous retinal arterial pulsation may occur because ocular perfusion pressure is critically low.

Cotton-Wool Spots

Cotton-wool spots may occur from focal retinal nerve fiber layer ischemia.

Choroidal Ischemia

Possible findings include:

• Patchy choroidal nonperfusion
• Peripheral wedge-shaped chorioretinal atrophy
• Delayed choroidal filling on angiography

Retinal and Disc Neovascularization

Chronic retinal ischemia can lead to:

• Neovascularization of the disc
• Neovascularization elsewhere
• Vitreous hemorrhage
• Neovascular glaucoma

Central Retinal Artery Occlusion

A cherry-red spot may occasionally occur if OIS is complicated by:

• Central retinal artery occlusion
• Severe acute arterial hypoperfusion

Orbital Infarction Syndrome

An extreme form of ischemia may involve both:

• Intraocular tissues
• Orbital tissues

Features may include:

• Severe orbital pain
• Ptosis
• Ophthalmoplegia
• Proptosis
• Corneal hypoesthesia
• Intraocular inflammation
• Hypotony

This represents severe compromise of orbital blood supply.

Systemic Examination

Examine for evidence of vascular disease.

Assessment should include:

• Blood pressure
• Peripheral pulses
• Carotid auscultation
• Cardiac examination

However, absence of a carotid bruit does not exclude severe carotid stenosis.

Fluorescein Angiography

FA is one of the most useful ocular diagnostic tests.

Delayed Choroidal Filling

The most characteristic finding is:

Delayed or patchy choroidal filling

This is one of the most specific angiographic signs of OIS.

Prolonged Arteriovenous Transit Time

A highly sensitive finding is:

Prolonged retinal arteriovenous transit

There may be markedly delayed passage of fluorescein from the retinal arteries into the veins.

Additional FA Findings

Other findings include:

• Retinal vascular staining
• Arterial wall staining
• Capillary nonperfusion
• Microaneurysms
• Disc leakage
• Macular leakage
• Slow leading edge of arterial dye

OCT

OCT may demonstrate:

• Macular edema
• Retinal thinning from chronic ischemia
• Inner retinal atrophy
• Secondary epiretinal changes

Macular edema in OIS is less common than in CRVO or diabetic retinopathy.

OCT Angiography

OCTA may help demonstrate:

• Reduced retinal capillary density
• Macular nonperfusion

However, it does not replace systemic vascular imaging.

Indocyanine Green Angiography

ICG may show:

• Delayed arm-to-choroid circulation
• Slow choroidal filling
• Abnormal watershed zones

It can further demonstrate choroidal vascular insufficiency.

Carotid Duplex Ultrasonography

Carotid Doppler ultrasound is commonly the initial noninvasive vascular test.

It evaluates:

• Degree of stenosis
• Flow velocity
• Plaque morphology
• Hemodynamics

Limitations include:

• Calcified plaque
• Tortuous vessels
• High cervical lesions
• Operator dependence

CTA and MRA

CT angiography and MR angiography provide detailed evaluation of:

• Carotid arteries
• Intracranial circulation
• Collateral circulation

These are particularly useful when:

• Duplex findings are inconclusive
• Surgical intervention is being considered
• Intracranial disease is suspected

Ophthalmic Artery Doppler

Retrobulbar Doppler may show:

Reversal of ophthalmic artery flow

This is a strong indicator of severe ipsilateral carotid occlusive disease with collateralization through the external carotid system.

Catheter Angiography

Digital subtraction angiography provides highly detailed vascular imaging but is invasive.

It is generally reserved for cases in which:

• Endovascular intervention is being considered
• Noninvasive imaging is inconclusive

Electroretinography

ERG may demonstrate impairment of both:

• Outer retina → reduced a-wave
• Inner retina → reduced b-wave

This reflects generalized retinal ischemia.

It is rarely needed for routine diagnosis.

Visual-Evoked Potentials

VEP may show:

• Reduced amplitude
• Increased latency

but is nonspecific and rarely central to diagnosis.

Giant Cell Arteritis Evaluation

If OIS-like findings occur in a patient with possible GCA, urgently consider:

• ESR
• CRP
• CBC with platelet count

Particularly ask about:

• New headache
• Jaw claudication
• Scalp tenderness
• Polymyalgia symptoms
• Constitutional symptoms

Differential Diagnosis

The two most important retinal mimics are:

• Central retinal vein occlusion
• Diabetic retinopathy

OIS vs Central Retinal Vein Occlusion

OIS typically shows:

• Narrow retinal arteries
• Dilated but minimally tortuous veins
• Midperipheral dot-blot hemorrhages
• Delayed choroidal filling
• Prolonged AV transit
• Possible low IOP

CRVO typically shows:

• Markedly dilated tortuous veins
• Extensive hemorrhage in all quadrants
• Disc edema
• Frequent macular edema
• Primarily venous outflow obstruction

OIS vs Diabetic Retinopathy

OIS is commonly:

• Unilateral or markedly asymmetric
• Associated with delayed choroidal filling
• Associated with midperipheral hemorrhage predominance

Diabetic retinopathy is usually:

• Bilateral
• More symmetric
• Characterized by posterior-pole microaneurysms and hemorrhages
• Often associated with hard exudates and diabetic macular edema

However, severe carotid disease can make diabetic retinopathy highly asymmetric.

Additional Differential Diagnosis

Consider:

• Ischemic CRVO
• Proliferative diabetic retinopathy
• Hypertensive retinopathy
• Retinal artery occlusion
• Giant cell arteritis
• Takayasu arteritis
• Hyperviscosity retinopathy
• Neovascular glaucoma from another cause

Treatment Principles

Management has three major objectives:

1. Restore or optimize ocular/systemic perfusion where possible
2. Treat retinal ischemia and neovascularization
3. Treat secondary complications such as neovascular glaucoma

Systemic vascular evaluation is essential because OIS often indicates potentially life-threatening vascular disease.

Systemic Vascular Management

All patients should undergo urgent medical evaluation for:

• Carotid disease
• Coronary artery disease
• Stroke risk
• Diabetes
• Hypertension
• Dyslipidemia

Management may include:

• Antiplatelet therapy when appropriate
• Statin therapy
• Blood pressure optimization
• Diabetes control
• Smoking cessation
• Weight management
• Exercise and dietary modification

These decisions should be coordinated with the appropriate medical or vascular team.

Carotid Revascularization

Carotid Endarterectomy

Carotid endarterectomy (CEA) may be indicated in selected patients with significant carotid stenosis, especially when the patient is symptomatic and operative risk is acceptable.

The decision depends on:

• Degree of stenosis
• Whether stenosis is symptomatic
• Overall neurologic risk
• Life expectancy
• Surgical risk
• Vascular anatomy

Because treatment guidelines evolve, these patients require vascular or stroke-specialist assessment rather than relying solely on a fixed percentage threshold.

Carotid Artery Stenting

Carotid artery stenting may be considered when:

• CEA carries excessive risk
• Anatomy is unfavorable for surgery
• Other vascular considerations favor an endovascular approach

Effect of Revascularization on the Eye

Improved carotid flow may:

• Improve ocular perfusion
• Reduce ischemic symptoms
• Reduce neovascular drive

The benefit is generally greatest before irreversible retinal damage or advanced neovascular glaucoma has developed.

Visual recovery is limited once severe retinal or optic nerve ischemia is established.

Panretinal Photocoagulation

PRP is used when there is retinal or anterior segment neovascularization from ischemia.

It can reduce VEGF production and help cause regression of:

• Iris neovascularization
• Disc neovascularization
• Retinal neovascularization

However, PRP may be less effective in OIS than in proliferative diabetic retinopathy because the entire ocular circulation is hypoperfused.

Anti-VEGF Therapy

Intravitreal anti-VEGF agents may produce rapid regression of:

• Iris neovascularization
• Angle neovascularization
• Retinal neovascularization

They may also help macular edema in selected patients.

However:

Anti-VEGF is an adjunct, not treatment of the underlying carotid hypoperfusion.

Its effect on neovascularization may be temporary unless the ischemic drive is also addressed.

Anterior Uveitis

Mild ischemic anterior inflammation may be treated with:

• Topical corticosteroids
• Cycloplegics

Cycloplegics can:

• Reduce ciliary spasm
• Improve pain
• Prevent posterior synechiae

Neovascular Glaucoma

NVG is a major vision-threatening complication.

Treatment includes:

• Anti-VEGF
• PRP when possible
• IOP-lowering therapy
• Anti-inflammatory treatment
• Glaucoma surgery when necessary

IOP-Lowering Medications

Aqueous suppressants are generally preferred:

• Beta-blockers
• Alpha-2 agonists
• Topical carbonic anhydrase inhibitors

Systemic carbonic anhydrase inhibitors may be considered in selected severe cases if medically appropriate.

Pilocarpine

Pilocarpine should generally be avoided in neovascular or inflamed eyes because it:

• Is usually ineffective in synechial angle closure
• Can worsen inflammation
• May increase discomfort

Prostaglandin Analogs

Prostaglandin analogs can lower IOP, but historically have been used cautiously in markedly inflamed ischemic eyes.

In modern practice they may still be considered when additional IOP reduction is needed and inflammation is controlled.

They are not absolutely contraindicated solely because OIS is present.

Glaucoma Surgery

If NVG remains uncontrolled, options include:

• Glaucoma drainage device
• Trabeculectomy in selected quiet eyes
• Cyclophotocoagulation

Tube shunts are often favored in eyes with active or previously active neovascularization.

Cyclodestructive Treatment

Cyclophotocoagulation may be especially useful when:

• Visual potential is poor
• Pain is significant
• IOP is refractory
• Incisional surgery is unlikely to succeed

Hypotony

If IOP is already low because of severe ciliary body ischemia:

IOP-lowering therapy should not be given simply because neovascularization is present.

Treatment must be tailored to the actual pressure and mechanism.

Referral

OIS should trigger multidisciplinary evaluation.

Appropriate referrals may include:

• Retina specialist
• Glaucoma specialist
• Primary care/internal medicine
• Neurology or stroke service
• Vascular surgery
• Cardiology

Urgency

New OIS is not merely an ophthalmic problem.

Because severe carotid disease may be present, patients need prompt systemic vascular assessment.

Urgency is particularly high with:

• Amaurosis fugax
• Recent neurologic symptoms
• Acute visual loss
• Known severe carotid stenosis

Follow-Up

Frequency depends on:

• Retinal ischemia
• Presence of neovascularization
• IOP
• Visual acuity
• Treatment status

Patients with active neovascularization or NVG require close follow-up.

Monitor:

• Iris
• Angle by gonioscopy
• IOP
• Retina
• Optic disc
• Macula

Patient Education

Patients should understand that OIS may represent:

Severe systemic vascular disease

They should seek urgent care for symptoms such as:

• Sudden weakness or numbness
• Facial droop
• Speech difficulty
• Sudden monocular visual loss
• Chest pain
• Severe new neurologic symptoms

Systemic Risk Modification

Long-term care should emphasize:

• Smoking cessation
• Diabetes control
• Blood pressure control
• Lipid management
• Appropriate antiplatelet/statin therapy
• Cardiovascular follow-up

Extreme lowering of systemic blood pressure should be avoided in patients with critically impaired ocular perfusion unless medically necessary.

Prognosis

Visual Prognosis

Visual prognosis is generally:

Guarded to poor

because presentation often occurs after substantial chronic ischemic damage.

Poor prognostic factors include:

• Severe visual loss at presentation
• Iris neovascularization
• Neovascular glaucoma
• Extensive retinal ischemia
• Advanced carotid disease

Once profound ischemic retinal damage has occurred, restoring carotid flow may not restore vision.

Systemic Prognosis

The systemic prognosis is also serious.

OIS is associated with substantial risk of:

• Stroke
• Myocardial infarction
• Cardiovascular death

Therefore, identifying OIS can be life-saving even when ocular visual recovery is limited.

Complications

Ocular complications include:

• Neovascular glaucoma
• Retinal neovascularization
• Vitreous hemorrhage
• Macular edema
• Cataract
• Hypotony
• Corneal decompensation
• Retinal artery occlusion
• Severe permanent visual loss

Systemic complications include:

• Cerebral infarction
• TIA
• Myocardial infarction
• Cardiovascular death

Ophthalmology Pearls

• OIS = chronic ocular hypoperfusion, most commonly from severe carotid occlusive disease.
• Classic presentation: progressive monocular visual loss + dull ocular/orbital pain in an older patient with vascular risk factors.
• Retinal findings classically include narrow arteries, dilated but relatively non-tortuous veins, and midperipheral dot-blot hemorrhages.
• Delayed patchy choroidal filling on fluorescein angiography is one of the most specific signs.
• Prolonged arteriovenous transit time is highly sensitive.
• IOP may be high from neovascular glaucoma or low from ciliary body ischemia.
• Rubeosis in OIS results from severe ischemia and may progress to neovascular glaucoma.
• Unlike CRVO, OIS veins are generally not markedly tortuous, and hemorrhages are often concentrated in the midperiphery.
• Carotid duplex is a common initial vascular study, with CTA/MRA used for further anatomic assessment.
• Anti-VEGF and PRP treat ocular neovascularization but do not correct the underlying carotid hypoperfusion.
• Carotid revascularization is most likely to benefit ocular perfusion before advanced irreversible retinal damage or NVG develops.
• OIS is a marker of potentially life-threatening vascular disease; systemic stroke and cardiovascular evaluation is mandatory.